Derek Archila Analyst PerformanceManaging Director, Biotechnology Equity Research at Wells Fargo & CompanyDerek Archila is a stock analyst at Wells Fargo & Company in the medical sector, covering 46 publicly traded companies. Over the past year, Derek Archila has issued 82 stock ratings, including buy and hold recommendations. While full access to Derek Archila's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Derek Archila's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings224 Last 9 YearsBuy Recommendations66.37% 148 Buy RatingsCompanies Covered46 Unique Companies Ratings Distribution223RatingsDistribution of strong buy, buy, hold, and sell ratings by Derek Archila.RatingPercentageCount Strong Buy0.4%1 ratings Buy65.9%147 ratings Hold33.6%75 ratings Sell0.0%0 ratingsOut of 223 total stock ratings issued by Derek Archila at Wells Fargo & Company, the majority (65.9%) have been Buy recommendations, followed by 33.6% Hold and 0.4% Strong Buy.Best & Worst CallsBest Call0000.0%ANABFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ANABNov 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ95.7% of companies on NASDAQ44 companiesNYSE4.3% of companies on NYSE2 companiesDerek Archila, an analyst at Wells Fargo & Company, currently covers 46 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical46 companies100.0%Derek Archila of Wells Fargo & Company specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE37 companies80.4%MED - DRUGS4 companies8.7%MED - GENERIC DRG2 companies4.3%PHARMACEUTICAL PREPARATIONS2 companies4.3%MED PRODUCTS1 company2.2% About Derek ArchilaSenior Equity Research Analyst specializing in small- and mid-cap biotechnology companies, with a primary focus on immunology & inflammation (I&I), targeted oncology, and rare diseases. I am a key contributor to the #4 ranked Wells Fargo SMID-cap biotech franchise, and was individually recognized as a “Runner-Up” in the Institutional Investor (Extel) poll for Biotechnology Small & Mid-Cap Equity Research in both 2023 and 2024, ranking among the top 5 analysts in 2024.Follow on LinkedIn Derek Archila's Ratings History at Wells Fargo & Company Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsALMSAlumis5/15/2026Boost Price Target$24.63$51.00Overweight$0.0000.00% ROICABACabaletta Bio5/15/2026Boost Price Target$3.51$4.00Equal Weight$0.0000.00% ROICLDXCelldex Therapeutics5/13/2026Boost Price Target$32.10$54.00Overweight$0.0000.00% ROIASNDAscendis Pharma A/S5/8/2026Lower Price Target$246.14$326.00Overweight$0.0000.00% ROIARGXargenex5/8/2026Boost Price Target$787.31$1,260.00Overweight$0.0000.00% ROIRYTMRhythm Pharmaceuticals5/6/2026Boost Price Target$93.83$144.00Overweight$0.0000.00% ROIALNYAlnylam Pharmaceuticals5/1/2026Boost Price Target$305.35$377.00Equal Weight$0.0000.00% ROISLNOSoleno Therapeutics4/17/2026Set Price Target$52.57$53.00Equal Weight$0.0000.00% ROIAPLSApellis Pharmaceuticals4/17/2026Downgrade$40.87$41.00Equal Weight$0.0000.00% ROISLNOSoleno Therapeutics4/17/2026Downgrade$52.78$53.00Equal Weight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. NRIXNurix Therapeutics4/9/2026Lower Price Target$15.80$28.00Overweight$0.0000.00% ROIVRDNViridian Therapeutics3/31/2026Lower Price Target$18.82$20.00Equal Weight$0.0000.00% ROIALXOALX Oncology3/19/2026Initiated Coverage$2.15$5.00Overweight$0.0000.00% ROIGLUEMonte Rosa Therapeutics3/18/2026Lower Price Target$16.03$29.00Overweight$0.0000.00% ROIRYTMRhythm Pharmaceuticals3/12/2026Boost Price Target$90.02$143.00Overweight$0.0000.00% ROISEPNSepterna3/3/2026Boost Price Target$27.47$48.00Overweight$0.0000.00% ROIIRONDisc Medicine3/2/2026Boost Price Target$65.48$79.00Overweight$0.0000.00% ROIARGXargenex2/27/2026Lower Price Target$775.04$1,247.00Overweight$0.0000.00% ROISLNOSoleno Therapeutics2/27/2026Lower Price Target$38.88$110.00Overweight$0.0000.00% ROIRYTMRhythm Pharmaceuticals2/27/2026Lower Price Target$93.22$136.00Overweight$0.0000.00% ROIIRONDisc Medicine2/17/2026Lower Price Target$55.99$78.00Overweight$0.0000.00% ROIBBIOBridgeBio Pharma2/13/2026Boost Price Target$74.58$98.00Overweight$0.0000.00% ROIINCYIncyte2/11/2026Lower Price Target$98.44$101.00Equal Weight$0.0000.00% ROIVRDNViridian Therapeutics2/3/2026Boost Price Target$33.20$29.00Equal Weight$0.0000.00% ROINRIXNurix Therapeutics1/29/2026Lower Price Target$17.87$29.00Overweight$0.0000.00% ROISLNOSoleno Therapeutics1/20/2026Reiterated Rating$42.48$114.00Overweight$0.0000.00% ROIRYTMRhythm Pharmaceuticals1/20/2026Boost Price Target$101.63$145.00Overweight$0.0000.00% ROIASNDAscendis Pharma A/S1/20/2026Boost Price Target$205.83$330.00Overweight$0.0000.00% ROIINCYIncyte1/20/2026Reiterated Rating$106.21$107.00Equal Weight$0.0000.00% ROIBBIOBridgeBio Pharma1/20/2026Boost Price Target$76.86$88.00Overweight$0.0000.00% ROIAPLSApellis Pharmaceuticals1/20/2026Lower Price Target$19.97$26.00Overweight$0.0000.00% ROIALNYAlnylam Pharmaceuticals1/20/2026Lower Price Target$348.61$376.00Equal Weight$0.0000.00% ROIARGXargenex1/20/2026Boost Price Target$798.13$1,317.00Overweight$0.0000.00% ROIINCYIncyte1/20/2026Downgrade$102.62$107.00Equal Weight$0.0000.00% ROIASNDAscendis Pharma A/S1/9/2026Boost Price Target$208.75$322.00Overweight$0.0000.00% ROIVTYXVentyx Biosciences1/8/2026Reiterated Rating$13.79$14.00Equal Weight$0.0000.00% ROIGLUEMonte Rosa Therapeutics1/8/2026Boost Price Target$25.37$30.00Overweight$0.0000.00% ROIVTYXVentyx Biosciences1/7/2026Downgrade$13.81Hold$0.0000.00% ROIALMSAlumis1/6/2026Boost Price Target$17.19$39.00Overweight$0.0000.00% ROIKYTXKyverna Therapeutics12/16/2025Boost Price Target$10.82$33.00Overweight$0.0000.00% ROITicker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.👉 Unlock the ticker now and get it completely free.NRIXNurix Therapeutics12/16/2025Boost Price Target$18.89$30.00Overweight$0.0000.00% ROIIRONDisc Medicine12/16/2025Boost Price Target$91.06$109.00Overweight$0.0000.00% ROIARGXargenex12/11/2025Boost Price Target$886.15$1,316.00Overweight$0.0000.00% ROIKYMRKymera Therapeutics12/9/2025Boost Price Target$94.30$116.00Overweight$0.0000.00% ROIORICOric Pharmaceuticals12/8/2025Boost Price Target$11.00$25.00Overweight$0.0000.00% ROIINCYIncyte12/8/2025Boost Price Target$102.52$116.00Overweight$0.0000.00% ROIANNXAnnexon11/19/2025Boost Price Target$3.20$27.00Overweight$0.0000.00% ROISEPNSepterna11/14/2025Upgrade$19.24$28.00Overweight$0.0000.00% ROIORICOric Pharmaceuticals11/14/2025Lower Price Target$12.84$19.00Overweight$0.0000.00% ROIBBIOBridgeBio Pharma11/11/2025Boost Price Target$63.20$84.00Overweight$0.0000.00% ROIALNYAlnylam Pharmaceuticals11/11/2025Boost Price Target$444.86$479.00Equal Weight$0.0000.00% ROIGLUEMonte Rosa Therapeutics11/7/2025Boost Price Target$12.24$13.00Equal Weight$0.0000.00% ROIVTYXVentyx Biosciences11/7/2025Boost Price Target$8.60$14.00Overweight$0.0000.00% ROIARVNArvinas11/6/2025Lower Price Target$9.81$15.00Overweight$0.0000.00% ROISLNOSoleno Therapeutics11/5/2025Reiterated Rating$63.85$106.00Overweight$0.0000.00% ROIKYMRKymera Therapeutics11/5/2025Boost Price Target$58.82$69.00Overweight$0.0000.00% ROIANABAnaptysBio11/5/2025Boost Price Target$36.13$81.00Overweight$0.0000.00% ROIKYTXKyverna Therapeutics10/29/2025Boost Price Target$7.82$31.00Overweight$0.0000.00% ROIINCYIncyte10/29/2025Boost Price Target$88.61$97.00Overweight$0.0000.00% ROINRIXNurix Therapeutics10/23/2025Lower Price Target$10.60$21.00Overweight$0.0000.00% ROIEXELExelixis10/21/2025Lower Price Target$34.54$30.00Equal Weight$0.0000.00% ROIKZRKezar Life Sciences10/17/2025Set Price Target$4.17$5.00Equal Weight$0.0000.00% ROIAPLSApellis Pharmaceuticals10/15/2025Initiated Coverage$23.15$32.00Overweight$0.0000.00% ROIKYTXKyverna Therapeutics10/8/2025Boost Price Target$5.41$27.00Overweight$0.0000.00% ROICCCCC4 Therapeutics9/23/2025Boost Price Target$2.61$10.00Overweight$0.0000.00% ROIATYRaTyr Pharma9/15/2025Reiterated Rating$1.05Equal Weight$0.0000.00% ROISLNOSoleno Therapeutics8/20/2025Initiated Coverage$66.81$123.00Overweight$0.0000.00% ROICLDXCelldex Therapeutics8/20/2025Lower Price Target$21.24$38.00Overweight$0.0000.00% ROISTROSutro Biopharma8/12/2025Lower Price Target$7.73$30.00Equal Weight$0.0000.00% ROIASNDAscendis Pharma A/S8/8/2025Reiterated Rating$190.35$295.00Overweight$0.0000.00% ROIZNTLZentalis Pharmaceuticals8/7/2025Lower Price Target$1.43$5.00Equal Weight$0.0000.00% ROIVRDNViridian Therapeutics8/7/2025Lower Price Target$16.71$26.00Equal Weight$0.0000.00% ROIARVNArvinas8/7/2025Lower Price Target$6.14$16.00Overweight$0.0000.00% ROIINCYIncyte8/6/2025Upgrade$77.72$89.00Overweight$0.0000.00% ROIARGXargenex7/31/2025Boost Price Target$670.33$756.00Overweight$0.0000.00% ROIINCYIncyte7/30/2025Boost Price Target$77.88$67.00Equal Weight$0.0000.00% ROIALMSAlumis7/25/2025Initiated Coverage$4.05$17.00Overweight$0.0000.00% ROIRYTMRhythm Pharmaceuticals7/10/2025Boost Price Target$89.53$129.00Overweight$0.0000.00% ROIKYMRKymera Therapeutics6/26/2025Lower Price Target$44.98$53.00Overweight$0.0000.00% ROIATYRaTyr Pharma6/20/2025Boost Price Target$5.17$25.00Overweight$0.0000.00% ROIBPMCBlueprint Medicines6/17/2025Downgrade$128.16$129.00Hold$0.0000.00% ROIAPLSApellis Pharmaceuticals6/2/2025Boost Price Target$19.21$29.00Equal Weight$0.0000.00% ROIAPLSApellis Pharmaceuticals5/8/2025Lower Price Target$17.90$26.00Equal Weight$00.0000.00% ROIARVNArvinas5/2/2025Lower Price Target$7.78$19.00Overweight$00.0000.00% ROIINCYIncyte4/30/2025Boost Price Target$61.16$59.00Equal Weight$00.0000.00% ROINRIXNurix Therapeutics4/9/2025Lower Price Target$9.86$25.00Overweight$00.0000.00% ROIRYTMRhythm Pharmaceuticals4/7/2025Boost Price Target$54.94$91.00Overweight$00.0000.00% ROIARVNArvinas3/12/2025Set Price Target$8.51$26.00Overweight$00.0000.00% ROIARGXargenex2/28/2025Boost Price Target$619.04$741.00Overweight$000.0000.00% ROIEXELExelixis2/24/2025Downgrade$36.85$36.00Equal Weight$00.0000.00% ROIBefore you buy SpaceX shares, consider this alternative approach (Ad)SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.Discover the overlooked SpaceX IPO strategy before the June listingANABAnaptysBio2/13/2025Boost Price Target$19.29$51.00Overweight$00.0000.00% ROIZNTLZentalis Pharmaceuticals1/30/2025Lower Price Target$1.66$6.00Equal Weight$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenJefferies Financial GroupWeiss RatingsUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.The Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
